The Effect of Weight Loss in Obese Patients with Chronic Stable Plaque-Type Psoriasis
Table 1
Baseline characteristics of patients.
Characteristic
Value
Gender male : female
7 : 3
Mean age, year (SD)
48.2 (7.6)
Mean duration of psoriasis, year (SD)
15.5 (9.1)
Mean BMI, kg/m2 (SD)
35.2 (6.3)
Mean body weight, kg (SD)
95.9 (23.6)
Mean waist, cm (SD)
112.3 (14.8)
Mean hip, cm (SD)
115.2 (9.5)
Mean fat mass, kg (SD)
38.6 (14.1)
Mean skeletal mass, kg (SD)
30.9 (6.91)
Mean systolic blood pressure, mmHg (SD)
130.3 (15.8)
Mean diastolic blood pressure, mmHg (SD)
81.8 (8.8)
Mean Psoriasis Area and Severity Index (SD)
5.72 (3.8)
Mean patient assessed by the physician as having moderate or high severity, %
60
Mean patient with self-assessed moderate or high severity, %
100
Mean overall treatment satisfaction score (SD)
1.60 (2.0)
Mean rash satisfaction score (SD)
1.60 (2.0)
Mean Dermatology Life Quality Index (SD)
8.00 (4.0)
Data are for patients with a baseline score of 3 (moderate), 4 (severe) or 5 (very severe) on the Physician’s Static Global Assessment; scores range from 0 to 5, with 0 indicating no evidence of plaque elevation, erythema, or scaling and 5 indicating severe induration, erythema, and scaling. Data are for patients with a psoriasis score of 3 to 5 on the Patient’s Global Assessment of Psoriasis; scores range from 0 to 5, with 0 indicating good and 5 indicating severe. The Dermatology Life Quality Index ranges from 0 to 30, with 0 indicating best and 30 indicating worst.
